Vilya

Biotechnology Research • South San Francisco, California, United States • 51-100 Employees

Company overview

Headquarters	South San Francisco, California, United States
Website	vilyatx.com
NAICS	541714
Employees	51-100
Socials

Key Contacts at Vilya

Inca Coman

Co-Founder And Advisor

Patrick Salveson

Co-Founder & Chief Technology Officer

Jeff Holden

Director And Head Of Structural Biology

Philip Cistrone

Associate Director, Chemistry

Beth Fernandez

Associate Director, Dmpk

Nao Hiranuma

Director Of Machine Learning Research / Co-Founder

Ivan Anishchenko

Senior Director Of Deep Learning

Vilya Email Formats

Vilya uses 2 email formats. The most common is {first name} (e.g., john@vilyatx.com), used 97.6% of the time.

Format	Example	Percentage
{first name}	john@vilyatx.com	97.6%
{first initial}	j@vilyatx.com	2.4%

About Vilya

Vilya is a cutting-edge computational biotechnology company, co-founded a team of scientists from from the Institute of Protein Design (IPD) led by David Baker, Ph.D. and by ARCH Venture Partners. At Vilya, we are creating a novel class of medicines to precisely target disease biology. Our platform is built on ground-breaking research in advanced computational approaches and taps into uncharted chemical space within cyclic peptides to design new molecular structures not found in nature. We aim to boldly leverage cutting edge computing to change how we design new medicines, and to ultimately cure diseases. Who will love working with us? We are a group of machine learning scientists, computational chemists, medicinal chemists, biologists and scientific enthusiasts that are driven to design and create life-altering medicines that will make a big impact on the world. Learn more about our job openings and join us! join@vilyatx.com

Vilya revenue & valuation

Annual revenue	$3,700,000
Revenue per employee	$69,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,900,000
Total funding	No funding